The interferon receptor-1 promoter polymorphisms affect the outcome of Caucasians with HBeAg-negative chronic HBV infection

The interferon receptor-1 promoter polymorphisms affect the outcome of Caucasians with HBeAg-negative chronic HBV infection

The outcome of HBeAg-negative chronic hepatitis B virus (HBV) patients who may remain in the inactive carrier state (IC) or progress to HBeAg-negative chronic hepatitis B may be affected by the host genetic profile. Genetic polymorphisms within not only the promoter but also the coding sequence of t...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Karamitros, T, Papatheodoridis, G, Dimopoulou, E, Papageorgiou, M, Paraskevis, D, Magiorkinis, G, Sypsa, V, Hatzakis, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	Wiley 2015

Documenti analoghi

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
Pubblicazione: (2006-01-01)

Correlation between HBsAg quantitation and HBV DNA in HBeAg-Negative HBV/D patients
di: Anouar Teriaky, et al.
Pubblicazione: (2013-01-01)

HBeAg-negative chronic hepatitis
di: M M Ibragimova, et al.
Pubblicazione: (2004-02-01)

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
di: Guangjun Song, et al.
Pubblicazione: (2023-11-01)

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
di: Xiaomei Wang, et al.
Pubblicazione: (2020-10-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
di: Cheng-Yuan Peng, et al.
Pubblicazione: (2015-04-01)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
di: Zhan Zeng, et al.
Pubblicazione: (2023-01-01)

Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B.
di: Thilde Nordmann Winther, et al.
Pubblicazione: (2013-01-01)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
di: Michel Bazinet, et al.
Pubblicazione: (2022-08-01)

Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
di: Ayub Al Mamun, et al.
Pubblicazione: (2013-01-01)

Immunomodulatory Function of HBeAg Related to Short-Sighted Evolution, Transmissibility, and Clinical Manifestation of Hepatitis B Virus
di: Anna Kramvis, et al.
Pubblicazione: (2018-10-01)

Envelope antibody HBeIgG and HBV DNA in HBeAg-seronegative young adults in Nigeria
di: Mathew Folaranmi Olaniyan, et al.
Pubblicazione: (2023-09-01)

Is the function of the HBeAg really unknown?
di: David R. Milich
Pubblicazione: (2019-09-01)

Mathematical investigation of HBeAg seroclearance
di: Sarah Kadelka, et al.
Pubblicazione: (2019-08-01)

HBeAg negative chronic hepatitis B in South Asia
di: Ananta Shrestha, et al.
Pubblicazione: (2016-11-01)

Impact of interferon-alpha receptor-1 promoter polymorphisms on the transcriptome of the hepatitis B virus-associated hepatocellular carcinoma
di: Karamitros, T, et al.
Pubblicazione: (2018)

Predictive significance of serum pgRNA in HBeAg clearance for chronic hepatitis B patients with low HBeAg level after pegylated interferon treatment
di: LIU Zhongwei, et al.
Pubblicazione: (2022-01-01)

Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
di: Kaimin Song, et al.
Pubblicazione: (2025-02-01)

Comparison of evolutionary patterns of different HBeAg status in HBV genotype B and C
di: Cai Ying, et al.
Pubblicazione: (2015-12-01)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
di: Crozier Sarah, et al.
Pubblicazione: (2008-04-01)

The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China.
di: Hui Wang, et al.
Pubblicazione: (2014-01-01)

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
di: Byung-Cheol Song, et al.
Pubblicazione: (2014-12-01)

Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
di: Timokratis Karamitros, et al.
Pubblicazione: (2018-04-01)

Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)/HBeAg(−) mothers
di: Meng Zhuo Cao, et al.
Pubblicazione: (2018-06-01)

Lamivudine therapy in HBeAg negative chronic hepatitis B patients
di: E. Guclu, et al.
Pubblicazione: (2014-04-01)

Increased Coffee Intake Reduces Circulating HBV DNA and HBsAg Levels in HBeAg-Negative Infection: A Cohort Study
di: Jack Bee Chook, et al.
Pubblicazione: (2019-09-01)

Manifestations of perihepatic lymph nodes in acute flare of chronic hepatitis B: association with HBeAg status and with HBeAg seroconversion.
di: Yen-Ling Ko, et al.
Pubblicazione: (2015-01-01)

Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection.
di: Victoria Therese Mücke, et al.
Pubblicazione: (2018-01-01)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
di: Chih-Chien Yao, et al.
Pubblicazione: (2017-05-01)

Phenotypes of peripheral CD4+ T helper cell subsets in pregnant women with HBeAg-negative chronic asymptomatic HBV carriers
di: Guofang Feng, et al.
Pubblicazione: (2023-02-01)

Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection
di: Anna D. Kosinska, et al.
Pubblicazione: (2021-07-01)

Caucasian Ethnicity, but Not Treatment Cessation Is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion
di: Stijn Van Hees, et al.
Pubblicazione: (2019-07-01)

Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia
di: Flamir da Silva Victoria, et al.

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
di: Ferruccio Bonino, et al.
Pubblicazione: (2022-07-01)

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
di: Tung-Hung Su, et al.
Pubblicazione: (2013-01-01)

A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues
di: Yan Gu, et al.
Pubblicazione: (2024-01-01)

IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B.
di: I-Cheng Lee, et al.
Pubblicazione: (2013-01-01)

Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase
di: Yuhua Gao, et al.
Pubblicazione: (2024-04-01)

Comparison of antibody response to hepatitis B vaccination in infants with positive or negative maternal hepatitis B e antigen (HBeAg) in cord blood: implication for the role of HBeAg as an immunotolerogen
di: Hongyu Huang, et al.
Pubblicazione: (2019-09-01)

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection
di: Jia-Feng Wu, et al.
Pubblicazione: (2024-05-01)